finance.yahoo.com
/1 month ago
Latest updates for Azn
Fresh curated links around AZN are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Attractive Growth Profile Positions AstraZeneca PLC (AZN) as Opportunity
- ANC
- AstraZeneca PLC (AZN) Q2 2026 Earnings Call Transcript
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
cafepharma.com
/1 month ago
ANC
ANC Anonymous (not verified) Tue, 08/04/2026 - 21:28 field_thread_url https://cafepharma.com/boards/threads/anc.712901/ board name...
genengnews.com
/1 month ago
AstraZeneca Licenses Global Rights to Dizal Lung Cancer Drug for Up-to-$1.5B
Dizal has been pursuing approvals from the FDA and China’s Center for Drug Evaluation (CDE) for a new indication for Zegfrovy, as a first-line treatment for NSCLC with exon 20 inse...
seekingalpha.com
/21 hours ago
AstraZeneca PLC (AZN) Presents at European Respiratory Society (ERS) Congress - Slideshow
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Azn
cafepharma.com
Recent coverage from public sources
Public source
feeds.feedburner.com
Recent coverage from public sources
Public source
finance.yahoo.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source